Fluorise N Eye Drop contains Neomycin 0.35% w/v + Fluorometholone 0.1% w/v, a dual-action ophthalmic formulation designed to treat bacterial eye infections while reducing associated inflammation. Its combination ensures rapid infection control with steroidal symptom relief.
Neomycin works by inhibiting bacterial protein synthesis, effectively treating a broad spectrum of ocular bacterial pathogens, while Fluorometholone suppresses inflammatory mediators, reducing redness, swelling, and discomfort.
From a commercial perspective, Fluorise N Eye Drop is a high-prescription ophthalmic antibiotic-steroid combination, widely used in eye hospitals, clinics, and post-operative care, ensuring strong repeat prescriptions and consistent demand.
Including Fluorise N Eye Drop in your portfolio strengthens the ophthalmic steroid-antibiotic segment, offering long-term business growth, prescriber trust, and enhanced portfolio credibility for PCD pharma franchise partners.